专利检索 ap:("Christopher I. Bayly" OR "Cameron Black" OR "Nathalie Ouimet" OR "David Percival" OR "Serge Leger" OR "Marc Ouellet") AND inv:"Serge Leger" 第 1 页

1.

发明授权
Bisaryl COX-2 inhibiting compounds, compositions and methods of use 失效
标题翻译：二芳基COX-2抑制化合物，组合物和使用方法

公开(公告)号：US5994379A

公开(公告)日：1999-11-30

申请号：US246925

申请日：1999-02-09

申请人： Christopher I. Bayly , Cameron Black , Nathalie Ouimet , David Percival , Serge Leger , Marc Ouellet

发明人： Christopher I. Bayly , Cameron Black , Nathalie Ouimet , David Percival , Serge Leger , Marc Ouellet

IPC分类号： C07D333/60 , A61K31/192 , A61K31/216 , A61K31/34 , A61K31/343 , A61K31/381 , A61K31/403 , A61K31/4035 , A61K31/404 , A61K31/41 , A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/437 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/495 , A61K31/496 , A61K31/4985 , A61P1/00 , A61P3/10 , A61P11/06 , A61P15/06 , A61P19/02 , A61P19/06 , A61P19/10 , A61P25/04 , A61P25/06 , A61P25/28 , A61P27/02 , A61P27/06 , A61P29/00 , A61P31/12 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07C57/42 , C07C59/64 , C07C69/618 , C07C69/734 , C07C323/62 , C07D209/08 , C07D209/18 , C07D209/44 , C07D213/55 , C07D213/64 , C07D213/69 , C07D235/08 , C07D263/56 , C07D277/64 , C07D307/79 , C07D333/54 , C07D471/04 , A61K31/425 , A61K31/19 , A61K31/215 , A61K31/38 , A61K31/42 , C07C57/38 , C07C321/28 , C07D235/06

CPC分类号： C07D213/64 , C07C323/62 , C07C57/42 , C07C59/64 , C07C69/618 , C07C69/734 , C07D209/08 , C07D209/44 , C07D213/55 , C07D213/69 , C07D235/08 , C07D263/56 , C07D277/64 , C07D307/79 , C07D333/54 , C07D471/04

摘要： The present invention relates to inhibitors of COX-2, compositions which contain such compounds and methods of use. The compounds are represented by formula I: ##STR1## and include pharmaceutically acceptable salts and esters thereof.

摘要翻译： 本发明涉及COX-2抑制剂，其含有这些化合物和使用方法的组合物。化合物由式I表示，并且包括其药学上可接受的盐和酯。

2.

发明申请
CATHEPSIN CYSTEINE PROTEASE INHIBITORS 有权

公开(公告)号：US20110230446A1

公开(公告)日：2011-09-22

申请号：US13115462

申请日：2011-05-25

申请人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Chirstophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

发明人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Chirstophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

IPC分类号： A61K31/277 , A61K31/495 , A61K31/4418 , A61K31/426 , A61K31/4174 , A61K31/663 , A61P19/08 , A61P19/10 , A61P1/02 , A61P19/02 , A61P35/00 , A61P19/00

CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04

摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

摘要翻译： 本发明涉及一类新的化合物，它们是半胱氨酸蛋白酶抑制剂，包括但不限于组织蛋白酶K，L，S和B的抑制剂。这些化合物可用于治疗其中指示抑制骨吸收的疾病，例如骨质疏松症

3.

发明申请
Cathepsin cysteine protease inhibitors 有权
标题翻译：组织蛋白酶半胱氨酸蛋白酶抑制剂

公开(公告)号：US20080188529A1

公开(公告)日：2008-08-07

申请号：US12082104

申请日：2008-04-08

申请人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

发明人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

IPC分类号： A61K31/4418 , C07C233/40 , A61K31/165 , C07D213/57

CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04

摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

摘要翻译： 本发明涉及一类新的化合物，它们是半胱氨酸蛋白酶抑制剂，包括但不限于组织蛋白酶K，L，S和B的抑制剂。这些化合物可用于治疗其中指示抑制骨吸收的疾病，例如骨质疏松症

4.

发明授权
Cathepsin cysteine protease inhibitors 有权
标题翻译：组织蛋白酶半胱氨酸蛋白酶抑制剂

公开(公告)号：US08318748B2

公开(公告)日：2012-11-27

申请号：US13115462

申请日：2011-05-25

申请人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

发明人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

IPC分类号： A61K31/4965 , A61K31/66 , A61K31/44 , A61K31/445 , A61K31/425 , A61K31/415

CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04

摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

摘要翻译： 本发明涉及一类新的化合物，它们是半胱氨酸蛋白酶抑制剂，包括但不限于组织蛋白酶K，L，S和B的抑制剂。这些化合物可用于治疗其中指示抑制骨吸收的疾病，例如骨质疏松症

5.

发明授权
Cathepsin cysteine protease inhibitors 有权
标题翻译：组织蛋白酶半胱氨酸蛋白酶抑制剂

公开(公告)号：US07973037B2

公开(公告)日：2011-07-05

申请号：US12082104

申请日：2008-04-08

申请人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

发明人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien , Michael J. Green , Bernard L. Hirschbein , James William Janc , James T. Palmer , Chitra Baskaran

IPC分类号： A61K31/535 , A61K31/497 , A61K31/435 , A61K31/385 , C07D265/30 , C07D241/04 , C07D211/08 , C07D333/02 , C07D255/03

CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04

摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

摘要翻译： 本发明涉及一类新的化合物，它们是半胱氨酸蛋白酶抑制剂，包括但不限于组织蛋白酶K，L，S和B的抑制剂。这些化合物可用于治疗其中指示抑制骨吸收的疾病，例如骨质疏松症

6.

发明授权
Cathepsin cysteine protease inhibitors 有权

公开(公告)号：US07375134B2

公开(公告)日：2008-05-20

申请号：US10505796

申请日：2003-02-28

申请人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien

发明人： Christopher I. Bayly , Cameron Black , Serge Leger , Chun Sing Li , Dan McKay , Christophe Mellon , Jacques Yves Gauthier , Vouy-Linh Truong , Cheuk Lau , Michel Therien

IPC分类号： A01N37/34

CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04

摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

7.

发明授权
Alkylated styrenes as prodrugs to COX-2 inhibitors 失效
标题翻译：烷基化苯乙烯作为前药转化为COX-2抑制剂

公开(公告)号：US5789413A

公开(公告)日：1998-08-04

申请号：US786517

申请日：1997-01-21

申请人： Cameron Black , Erich Grimm , Serge Leger , Greg Hughes , Petpiboon Prasit , Zhaoyin Wang

发明人： Cameron Black , Erich Grimm , Serge Leger , Greg Hughes , Petpiboon Prasit , Zhaoyin Wang

IPC分类号： C07C311/29 , C07C317/22 , C07C317/24 , C07C317/44 , C07C317/46 , C07D307/58 , C07D307/60 , C07D307/64 , C07D307/66 , C07D307/94 , C07D405/12 , A61K31/10 , A61K31/165 , C07C59/42 , C07C317/14

CPC分类号： C07D405/12 , C07C311/29 , C07C317/22 , C07C317/24 , C07C317/44 , C07C317/46 , C07D307/58 , C07D307/60 , C07D307/64 , C07D307/66 , C07D307/94

摘要： The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

摘要翻译： 本发明包括可用于治疗环氧合酶-2介导的疾病的新颖的式I化合物。本发明还包括用于治疗包含式I化合物的环氧合酶-2介导的疾病的某些药物组合物。

8.

发明授权
3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors 失效
标题翻译： 3,4-二芳基-2-羟基-2,5-二氢呋喃作为COX-2抑制剂的前药

公开(公告)号：US5698584A

公开(公告)日：1997-12-16

申请号：US738143

申请日：1996-10-25

申请人： Cameron Black , Serge Leger , Petpiboon Prasit , Zhaoyin Wang , Pierre Hamel , Yongxin Han , Gregory Hughes

发明人： Cameron Black , Serge Leger , Petpiboon Prasit , Zhaoyin Wang , Pierre Hamel , Yongxin Han , Gregory Hughes

IPC分类号： C07C317/22 , C07C323/64 , C07D213/34 , C07D307/30 , C07D307/32 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/94 , C07D405/04 , C07D405/12 , C07D409/12 , C07D417/12 , C07F9/117 , A61K31/34

CPC分类号： C07D307/32 , C07C317/22 , C07C323/64 , C07D213/34 , C07D307/30 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/94 , C07D405/04 , C07D405/12 , C07D409/12 , C07D417/12 , C07F9/117

摘要： The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

摘要翻译： 本发明包括可用于治疗环氧合酶-2介导的疾病的新颖的式I化合物。本发明还包括用于治疗包含式I化合物的环氧合酶-2介导的疾病的某些药物组合物。

9.

发明申请
Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase 审中-公开
标题翻译：杂芳族化合物作为硬脂酰辅酶A Delta-9去饱和酶的抑制剂

公开(公告)号：US20090118296A1

公开(公告)日：2009-05-07

申请号：US11988192

申请日：2006-07-18

申请人： Cameron Black , Denis Deschenes , Marc Gagnon , Nicolas Lachance , Yves LeBlanc , Serge Leger , Chun Sing Li , Renata M. Oballa

发明人： Cameron Black , Denis Deschenes , Marc Gagnon , Nicolas Lachance , Yves LeBlanc , Serge Leger , Chun Sing Li , Renata M. Oballa

IPC分类号： A61K31/501 , C07D417/14 , A61P3/00

CPC分类号： C07D413/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , C07D413/04 , C07D417/14 , C07D471/04 , C07F9/65583

摘要： Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; lipid disorders; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and fatty liver disease.

摘要翻译： 结构式（I）的杂芳族化合物是相对于其他已知的硬脂酰辅酶A去饱和酶的硬脂酰辅酶Aδ-9去饱和酶（SCD1）的选择性抑制剂。本发明的化合物可用于预防和治疗与脂质合成和代谢异常有关的病症，包括心血管疾病; 动脉粥样硬化脂质紊乱肥胖; 糖尿病; 神经系统疾病; 代谢综合征; 胰岛素抵抗; 和脂肪肝病。